Inhibition of ion channels and heart beat in drosophila by selective COX-2 inhibitor SC-791

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Frolov, Roman V ^a,b   Singh, Satpal ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ION CHANNEL; ISRADIPINE; LINOPIRDINE; PAXILLINE; QUINIDINE; RYANODINE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SC 791; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; ISOXAZOLE DERIVATIVE; SULFONAMIDE;

ARTICLE; CALCIUM TRANSPORT; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DROSOPHILA; EXCITATION CONTRACTION COUPLING; HEART ARRHYTHMIA; HEART BEAT; HEART CONTRACTION; HEART MUSCLE CELL; ION CURRENT; LARVA; NONHUMAN; PACEMAKER; POTASSIUM CURRENT; SARCOPLASMIC RETICULUM; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HEART RATE; PHYSIOLOGY;

ANIMALS; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DROSOPHILA; HEART RATE; ION CHANNELS; ISOXAZOLES; ISRADIPINE; LARVA; MYOCARDIAL CONTRACTION; SULFONAMIDES;

EID: 84862025137     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038759     Document Type: Article

References (39)

1. Dogne JM, Thiry A, Pratico D, Masereel B, Supuran CT, (2007) Dual carbonic anhydrase-cyclooxygenase-2 inhibitors. Curr Top Med Chem 7: 885 891.
2. Zhang Y, Tao J, Huang H, Ding G, Cheng Y, (2007) Effects of celecoxib on voltage-gated calcium channel currents in rat pheochromocytoma (PC12) cells. Pharmacol Res 56: 267 274.
3. Park SY, Kim TH, Kim HI, Shin YK, Lee CS, (2007) Celecoxib inhibits Na+ currents in rat dorsal root ganglion neurons. Brain Res 1148: 53 61.
4. Brueggemann LI, Mackie AR, Mani BK, Cribbs LL, Byron KL, (2009) Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles. Mol Pharmacol 76: 1053 1061.
5. Arias OII, Carrillo E, Meza-Torres B, Barriga-Montoya C, Balleza D, (2011) Induction of a fast inactivation gating on delayed rectifier Shab K (+) channels by the anti-inflammatory drug celecoxib. Channels (Austin) 5.
6. Hasinoff BB, Patel D, Wu X, (2007) The cytotoxicity of celecoxib towards cardiac myocytes is cyclooxygenase-2 independent. Cardiovasc Toxicol 7: 19 27.
7. Grosch S, Maier TJ, Schiffmann S, Geisslinger G, (2006) Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98: 736 747.
8. Frolov RV, Berim IG, Singh S, (2008) Inhibition of delayed rectifier potassium channels and induction of arrhythmia: a novel effect of celecoxib and the mechanism underlying it. J Biol Chem 283: 1518 1524.
9. Frolov RV, Slaughter MM, Singh S, (2008) Effects of celecoxib on ionic currents and spontaneous firing in rat retinal neurons. Neuroscience.
10. Frolov RV, Bondarenko VE, Singh S, (2010) Mechanisms of Kv2.1 channel inhibition by celecoxib-modification of gating and channel block. Br J Pharmacol 159: 405 418.
11. Macias A, Moreno C, Moral-Sanz J, Cogolludo A, David M, (2010) Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials. J Mol Cell Cardiol 49: 984 992.
12. Frolov RV, Ignatova II, Singh S, (2011) Inhibition of HERG potassium channels by celecoxib and its mechanism. PLoS One 6: e26344.
13. Frolov RV, Ignatova II, Singh S, (2010) Mechanism of K(v)2.1 channel inhibition by a selective COX-2 inhibitor SC-791-modification of gating. Brain Res 1359: 67 74.
14. Yefi R, Ponce DP, Niechi I, Silva E, Cabello P, (2011) Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production. J Cell Biochem 112: 3167 3175.
15. Blomme EA, Chinn KS, Hardy MM, Casler JJ, Kim SH, (2003) Selective cyclooxygenase-2 inhibition does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 mice. Br J Dermatol 148: 211 223.
16. Jeong HS, Kim JH, Choi HY, Lee ER, Cho SG, (2010) Induction of cell growth arrest and apoptotic cell death in human breast cancer MCF-7 cells by the COX-1 inhibitor FR122047. Oncol Rep 24: 351 356.
17. Hardy MM, Blomme EA, Lisowski A, Chinn KS, Jones A, (2003) Selective cyclooxygenase-2 inhibition does not alter keratinocyte wound responses in the mouse epidermis after abrasion. J Pharmacol Exp Ther 304: 959 967.
18. Tripp CS, Blomme EA, Chinn KS, Hardy MM, LaCelle P, (2003) Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection. J Invest Dermatol 121: 853 861.
19. Gielow ML, Gu GG, Singh S, (1995) Resolution and pharmacological analysis of the voltage-dependent calcium channels of Drosophila larval muscles. J Neurosci 15: 6085 6093.
20. Bhattacharya A, Gu GG, Singh S, (1999) Modulation of dihydropyridine-sensitive calcium channels in Drosophila by a cAMP-mediated pathway. J Neurobiol 39: 491 500.
21. Gu GG, Singh S, (1997) Modulation of the dihydropyridine-sensitive calcium channels in Drosophila by a phospholipase C-mediated pathway. J Neurobiol 33: 265 275.
22. Hegde P, Gu GG, Chen D, Free SJ, Singh S, (1999) Mutational analysis of the Shab-encoded delayed rectifier K(+) channels in Drosophila. J Biol Chem 274: 22109 22113.
23. Singh S, Wu CF, (1999) Ionic currents in larval muscles of Drosophila. Int Rev Neurobiol 43: 191 220.
24. Singh A, Singh S, (1999) Unmasking of a novel potassium current in Drosophila by a mutation and drugs. J Neurosci 19: 6838 6843.
25. Johnson E, Sherry T, Ringo J, Dowse H, (2002) Modulation of the cardiac pacemaker of Drosophila: cellular mechanisms. J Comp Physiol B 172: 227 236.
26. Johnson E, Ringo J, Dowse H, (1997) Modulation of Drosophila heartbeat by neurotransmitters. J Comp Physiol B 167: 89 97.
27. Johnson E, Ringo J, Bray N, Dowse H, (1998) Genetic and pharmacological identification of ion channels central to the Drosophila cardiac pacemaker. J Neurogenet 12: 1 24.
28. Ocorr K, Reeves NL, Wessells RJ, Fink M, Chen HS, (2007) KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging. Proc Natl Acad Sci U S A 104: 3943 3948.
29. Robbins J, Aggarwal R, Nichols R, Gibson G, (1999) Genetic variation affecting heart rate in Drosophila melanogaster. Genet Res 74: 121 128.
30. Sullivan KM, Scott K, Zuker CS, Rubin GM, (2000) The ryanodine receptor is essential for larval development in Drosophila melanogaster. Proc Natl Acad Sci U S A 97: 5942 5947.
31. Sanyal S, Jennings T, Dowse H, Ramaswami M, (2006) Conditional mutations in SERCA, the Sarco-endoplasmic reticulum Ca2+-ATPase, alter heart rate and rhythmicity in Drosophila. J Comp Physiol B 176: 253 263.
32. Bliss CI, (1939) The toxicity of poisons applied jointly. Annals of Applied Biology 26: 585 615.
33. Dressler V, Muller G, Suhnel J, (1999) CombiTool-a new computer program for analyzing combination experiments with biologically active agents. Comput Biomed Res 32: 145 160.
34. Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, (2009) Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrob Agents Chemother 53: 2382 2391.
35. Gu GG, Singh S, (1995) Pharmacological analysis of heartbeat in Drosophila. J Neurobiol 28: 269 280.
36. Peron S, Zordan MA, Magnabosco A, Reggiani C, Megighian A, (2009) From action potential to contraction: neural control and excitation-contraction coupling in larval muscles of Drosophila. Comp Biochem Physiol A Mol Integr Physiol 154: 173 183.
37. Fill M, Copello JA, (2002) Ryanodine receptor calcium release channels. Physiol Rev 82: 893 922.
38. Chopra M, Gu GG, Singh S, (2000) Mutations affecting the delayed rectifier potassium current in Drosophila. J Neurogenet 14: 107 123.
39. Bate M, (1990) The embryonic development of larval muscles in Drosophila. Development 110: 791 804.